Translocator protein (TSPO)-Targeted agents for photodynamic therapy of cancer
Authors:
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 34, 102209
Abstract
No abstract availableKeywords
Funding Information
- American Cancer Society (RSG-17-131-01-CDD)
This publication has 23 references indexed in Scilit:
- Synthesis and Biological Evaluation of 4-Phenylquinazoline-2-carboxamides Designed as a Novel Class of Potent Ligands of the Translocator ProteinJournal of Medicinal Chemistry, 2012
- NIR-mbc94, a Fluorescent Ligand that Binds to Endogenous CB2 Receptors and Is Amenable to High-Throughput ScreeningChemistry & Biology, 2011
- NIR dyes for bioimaging applicationsCurrent Opinion in Chemical Biology, 2010
- Synthesis and Biological Evaluation of Substituted [18F]Imidazo[1,2-a]pyridines and [18F]Pyrazolo[1,5-a]pyrimidines for the Study of the Peripheral Benzodiazepine Receptor Using Positron Emission TomographyJournal of Medicinal Chemistry, 2008
- A Novel Functional Translocator Protein Ligand for Cancer ImagingBioconjugate Chemistry, 2007
- A Novel Conjugable Translocator Protein Ligand Labeled with a Fluorescence Dye for in Vitro ImagingBioconjugate Chemistry, 2007
- A Peripheral Benzodiazepine Receptor Targeted Agent for In Vitro Imaging and ScreeningBioconjugate Chemistry, 2006
- Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligandBioorganic & Medicinal Chemistry, 2005
- Mechanisms in photodynamic therapy: part one—photosensitizers, photochemistry and cellular localizationPhotodiagnosis and Photodynamic Therapy, 2004
- Expression of Peripheral Benzodiazepine Receptor (PBR) in Human Tumors: Relationship to Breast, Colorectal, and Prostate Tumor ProgressionJournal of Receptors and Signal Transduction, 2003